These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 23324778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Toxic epidermal necrolysis associated with the use of levetiracetam.
    Sierra-Gordillo Y, Peñaranda-Contreras E, Gomez Arbeláez MM, Moreno-Lucero PA.
    Clin Toxicol (Phila); 2024 Mar; 62(3):201-202. PubMed ID: 38619013
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD, Thompson DS.
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A topical matter: toxic epidermal necrolysis.
    Ladizinski B, Sankey C.
    Am J Med; 2014 Oct; 127(10):931-2. PubMed ID: 24950488
    [No Abstract] [Full Text] [Related]

  • 8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 9. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
    Wolkenstein P.
    Therapie; 1996 Feb; 51(5):500-1. PubMed ID: 9138383
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F.
    N Engl J Med; 1995 Dec 14; 333(24):1600-7. PubMed ID: 7477195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lamotrigine and toxic epidermal necrolysis.
    Wadelius M, Karlsson T, Wadelius C, Rane A.
    Lancet; 1996 Oct 12; 348(9033):1041. PubMed ID: 8855897
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.